SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | -55.3% | 1 | 0.0% | 0.00% | – |
| Q2 2023 | $47 | +11.9% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $42 | +10.5% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $38 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | -93.3% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 15 | -71.2% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 52 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | +100.0% | 52 | +173.7% | 0.00% | – |
| Q2 2021 | $1,000 | – | 19 | +90.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 10 | -95.6% | 0.00% | -100.0% |
| Q4 2019 | $16,000 | -48.4% | 226 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $31,000 | -22.5% | 226 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $40,000 | +14.3% | 226 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $35,000 | +105.9% | 226 | +25.6% | 0.00% | +50.0% |
| Q4 2018 | $17,000 | -29.2% | 180 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $24,000 | -11.1% | 180 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $27,000 | +237.5% | 180 | +221.4% | 0.00% | +100.0% |
| Q1 2018 | $8,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
| Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
| Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
| Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
| PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
| EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
| Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
| Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
| SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
| CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |